Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.

How lipopolysaccharide (LPS) signals through toll-like receptors (TLRs) to induce nuclear factor (NF)-kappa B inflammatory cytokines in sepsis remains unclear. Major candidates for that process are myeloid differentiation protein 88 (MyD88) and MyD88 adaptor-like/TIR domain-containing adaptor protei...

Full description

Bibliographic Details
Main Authors: Andreakos, E, Sacre, S, Smith, C, Lundberg, A, Kiriakidis, S, Stonehouse, T, Monaco, C, Feldmann, M, Foxwell, B
Format: Journal article
Language:English
Published: 2004
_version_ 1797070955125669888
author Andreakos, E
Sacre, S
Smith, C
Lundberg, A
Kiriakidis, S
Stonehouse, T
Monaco, C
Feldmann, M
Foxwell, B
author_facet Andreakos, E
Sacre, S
Smith, C
Lundberg, A
Kiriakidis, S
Stonehouse, T
Monaco, C
Feldmann, M
Foxwell, B
author_sort Andreakos, E
collection OXFORD
description How lipopolysaccharide (LPS) signals through toll-like receptors (TLRs) to induce nuclear factor (NF)-kappa B inflammatory cytokines in sepsis remains unclear. Major candidates for that process are myeloid differentiation protein 88 (MyD88) and MyD88 adaptor-like/TIR domain-containing adaptor protein (Mal/TIRAP) but their role needs to be further defined. Here, we have examined the role of MyD88 and Mal/TIRAP in primary human cells of nonmyeloid and myeloid origin as physiologically relevant systems. We found that MyD88 and Mal/TIRAP are essential for LPS-induced I kappa B alpha phosphorylation, NF-kappa B activation, and interleukin 6 (IL-6) or IL-8 production in fibroblasts and endothelial cells in a pathway that also requires IKK2. In contrast, in macrophages neither MyD88, Mal/TIRAP, nor I kappa B kinase 2 (IKK2) are required for NF-kappa B activation or tumor necrosis factor alpha (TNF alpha), IL-6, or IL-8 production, although Mal/TIRAP is still involved in the production of interferon beta (IFN beta). Differential usage of TLRs may account for that, as in macrophages but not fibroblasts or endothelial cells, TLR4 is expressed in high levels at the cell surface, and neutralization of TLR4 but not TLR2 blocks LPS signaling. These observations demonstrate for the first time the existence of 2 distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of TLR4, MyD88, Mal/TIRAP, and IKK2, and reveal a layer of complexity not previously expected.
first_indexed 2024-03-06T22:46:19Z
format Journal article
id oxford-uuid:5d4c60be-8865-49fa-b69a-7643e3c1ecf9
institution University of Oxford
language English
last_indexed 2024-03-06T22:46:19Z
publishDate 2004
record_format dspace
spelling oxford-uuid:5d4c60be-8865-49fa-b69a-7643e3c1ecf92022-03-26T17:33:32ZDistinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5d4c60be-8865-49fa-b69a-7643e3c1ecf9EnglishSymplectic Elements at Oxford2004Andreakos, ESacre, SSmith, CLundberg, AKiriakidis, SStonehouse, TMonaco, CFeldmann, MFoxwell, BHow lipopolysaccharide (LPS) signals through toll-like receptors (TLRs) to induce nuclear factor (NF)-kappa B inflammatory cytokines in sepsis remains unclear. Major candidates for that process are myeloid differentiation protein 88 (MyD88) and MyD88 adaptor-like/TIR domain-containing adaptor protein (Mal/TIRAP) but their role needs to be further defined. Here, we have examined the role of MyD88 and Mal/TIRAP in primary human cells of nonmyeloid and myeloid origin as physiologically relevant systems. We found that MyD88 and Mal/TIRAP are essential for LPS-induced I kappa B alpha phosphorylation, NF-kappa B activation, and interleukin 6 (IL-6) or IL-8 production in fibroblasts and endothelial cells in a pathway that also requires IKK2. In contrast, in macrophages neither MyD88, Mal/TIRAP, nor I kappa B kinase 2 (IKK2) are required for NF-kappa B activation or tumor necrosis factor alpha (TNF alpha), IL-6, or IL-8 production, although Mal/TIRAP is still involved in the production of interferon beta (IFN beta). Differential usage of TLRs may account for that, as in macrophages but not fibroblasts or endothelial cells, TLR4 is expressed in high levels at the cell surface, and neutralization of TLR4 but not TLR2 blocks LPS signaling. These observations demonstrate for the first time the existence of 2 distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of TLR4, MyD88, Mal/TIRAP, and IKK2, and reveal a layer of complexity not previously expected.
spellingShingle Andreakos, E
Sacre, S
Smith, C
Lundberg, A
Kiriakidis, S
Stonehouse, T
Monaco, C
Feldmann, M
Foxwell, B
Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
title Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
title_full Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
title_fullStr Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
title_full_unstemmed Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
title_short Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
title_sort distinct pathways of lps induced nf kappa b activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of myd88 and mal tirap
work_keys_str_mv AT andreakose distinctpathwaysoflpsinducednfkappabactivationandcytokineproductioninhumanmyeloidandnonmyeloidcellsdefinedbyselectiveutilizationofmyd88andmaltirap
AT sacres distinctpathwaysoflpsinducednfkappabactivationandcytokineproductioninhumanmyeloidandnonmyeloidcellsdefinedbyselectiveutilizationofmyd88andmaltirap
AT smithc distinctpathwaysoflpsinducednfkappabactivationandcytokineproductioninhumanmyeloidandnonmyeloidcellsdefinedbyselectiveutilizationofmyd88andmaltirap
AT lundberga distinctpathwaysoflpsinducednfkappabactivationandcytokineproductioninhumanmyeloidandnonmyeloidcellsdefinedbyselectiveutilizationofmyd88andmaltirap
AT kiriakidiss distinctpathwaysoflpsinducednfkappabactivationandcytokineproductioninhumanmyeloidandnonmyeloidcellsdefinedbyselectiveutilizationofmyd88andmaltirap
AT stonehouset distinctpathwaysoflpsinducednfkappabactivationandcytokineproductioninhumanmyeloidandnonmyeloidcellsdefinedbyselectiveutilizationofmyd88andmaltirap
AT monacoc distinctpathwaysoflpsinducednfkappabactivationandcytokineproductioninhumanmyeloidandnonmyeloidcellsdefinedbyselectiveutilizationofmyd88andmaltirap
AT feldmannm distinctpathwaysoflpsinducednfkappabactivationandcytokineproductioninhumanmyeloidandnonmyeloidcellsdefinedbyselectiveutilizationofmyd88andmaltirap
AT foxwellb distinctpathwaysoflpsinducednfkappabactivationandcytokineproductioninhumanmyeloidandnonmyeloidcellsdefinedbyselectiveutilizationofmyd88andmaltirap